Funding Rounds
Nouscom

Nouscom Series C (2024, $82M)

Nouscom

Viral vector-based cancer vaccines developer.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series C

Raised Amount: $82.89M

Investors